Immune Mediated Disorders
Immune mediated disorders occur when the body's immune system, which normally
protects us against infection, doesn’t function properly. The result: people
affected by this condition are more susceptible to disease.
There are a wide variety of immune mediated disorders, two of which are
primary immunodeficiency (PI) and immune/idiopathic thrombocytopenic purpura
(ITP).
ZLB Behring offers two high-quality products for the treatment of these
conditions: Carimune® NF Immune Globulin Intravenous (Human) for the
treatment of PI and ITP and Vivaglobin® Immune Globulin Subcutaneous
(Human) for the treatment of PI.
For more information on these products, please click on the links
below.
Carimune® NF
Immune
Globulin Intravenous (Human)
Warning: Immune Globulin Intravenous (Human) (IGIV) products have been reported to be associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. See boxed warning and the PRECAUTIONS and DOSAGE AND ADMINISTRATION section of
Full Prescribing Information for Carimune® NF Nanofiltered
for important information intended to reduce the risk of acute renal failure.
Vivaglobin®
Immune Globulin Subcutaneous
(Human)
To learn more about each of these conditions, please click on the links
below.
Primary Immunodeficiency
Immune/Idiopathic Thrombocytopenic Purpura
For more information on immunoglobulin (Ig) treatment options, please
click on the link below.
Immunoglobulin Treatment Options